期刊文献+

42例缺血性脑血管病合并糖尿病的临床疗效分析

Analysis of Clinical Curative Effect of 42 Cases of Ischemic Cerebrovascular Disease Complicated with Diabetes Mellitus
下载PDF
导出
摘要 目的对42例缺血性脑血管病合并糖尿病的临床疗效进行讨论分析。方法选择该院2019年8月—2020年8月期间收治的42例缺血性脑血管病合并糖尿病患者为研究样本,根据随机原则,将所有患者分成对照组与研究组,每组21例。对照组患者采用复方丹参注射液治疗,研究组应用银杏达莫注射液进行治疗,对两组患者临床治疗有效率、治疗前后神经功能缺损情况以及不同观察指标情况进行对比。结果研究组治疗有效率为95.24%,对照组治疗有效率为57.14%,两组相比,研究组显著高于对照组,差异有统计学意义(χ^(2)=8.400,P<0.05);两组患者在治疗前,评分差异无统计学意义(P>0.05),经过治疗后,两组患者神经功能缺损程度情况都呈显著下降趋势,差异有统计学意义(t=4.385、5.185,P<0.05),研究组评分情况相较于对照组更低,组间对比差异有统计学意义(t=2.395,P=0.021);两组患者治疗前,纤维蛋白原、三酰甘油、血浆黏度等指标对比,差异无统计学意义(P>0.05),经过治疗,研究组各项指标情况明显低于对照组,差异有统计学意义(t=2.312,P=0.026;t=3.907,P<0.001;t=2.946,P=0.017)。结论针对糖尿病进行治疗,重视控制血糖的同时,可以将银杏达莫注射液当作重要的治疗方案,从而促进患者神经缺损程度趋于改善,强化治疗效果。 Objective To discuss and analyze the clinical efficacy of 42 cases of ischemic cerebrovascular disease complicated with diabetes.Methods 42 patients with ischemic cerebrovascular disease and diabetes mellitus admitted to the hospital from August 2019 to August 2020 were selected as the study samples.According to the principle of randomization,all patients were divided into control group and study group,with 21 cases in each group.The control group was treated with compound Danshen injection,and the study group was treated with Ginkgo Damo injection.The clinical treatment efficiency,neurological deficits before and after treatment,and different observation indexes were compared between the two groups.Results The effective rate of treatment in the study group was 95.24%,and that in the control group was 57.14%.Compared with the two groups,the study group was significantly higher than the control group,and the difference was statistically significant(χ^(2)=8.400,P<0.05).Before treatment,there was no statistically significant difference in scores(P>0.05).After treatment,the neurological deficits of the two groups showed a significant downward trend,and the difference was statistically significant(t=4.385,5.185,P<0.05).The score of the study group was lower than that of the control group,and the difference between the groups was statistically significant(t=2.395,P=0.021);before treatment,the two groups of patients had fibrinogen,triglycerides,plasma viscosity and other indicators in contrast,there was no statistically significant difference(P>0.05).After treatment,the indicators of the study group were significantly lower than those of the control group,and the difference was statistically significant(t=2.312,P=0.026;t=3.907,P<0.001;t=2.946,P=0.017).Conclusion For the treatment of diabetes,while paying attention to blood sugar control,Ginkgo Damo injection can be used as an important treatment plan,so as to promote the improvement of the patient's nerve defect and strengthen the treatment effect.
作者 陈捷 CHEN Jie(Emergency Department,the Fifth Hospital of Daqing City,Daqing,Heilongjiang Province,163714 China)
出处 《糖尿病新世界》 2021年第11期39-42,共4页 Diabetes New World Magazine
关键词 缺血性脑血管病 糖尿病 临床疗效 Ischemic cerebrovascular disease Diabetes Clinical efficacy
  • 相关文献

参考文献14

二级参考文献121

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部